Profile
Stephen B.
Ruddy worked as Senior Director-Technology Development at Shire ViroPharma, Inc. from 2012 to 2014.
He then worked as Vice President-Pharmaceutical Development at Tesaro, Inc. from 2015 to 2018.
Ruddy's former job titles culminated in his role as Chief Technical Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Ruddy earned an undergraduate and doctorate degree from The University of North Carolina at Chapel Hill.
Former positions of Stephen Ruddy
| Companies | Position | End |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 2018-04-30 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | 2014-11-30 |
| DECIPHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Stephen Ruddy
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Stephen Ruddy
